[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-hc-wainwright-has-optimistic-v330195948d-919e-785a-ab44-832b2c97d034":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23},"hc-wainwright-has-optimistic-v330195948d-919e-785a-ab44-832b2c97d034","1741952625000","HC Wainwright Has Optimistic View of TSE:ONC FY2026 Earnings","Oncolytics Biotech Inc. (TSE:ONC - Free Report) - Equities researchers at  HC Wainwright boosted their FY2026 earnings per share (EPS) estimates for Oncolytics Biotech  in a research report issued on  Monday, March 10th. HC Wainwright analyst P. Trucchio now expects that the company will post earnin","https://www.marketbeat.com/instant-alerts/hc-wainwright-has-optimistic-view-of-tseonc-fy2026-earnings-2025-03-13/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"\",\"-\"]","[{\"name\":\"\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/blockchains/.png\"},{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","2"]